2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
September 5th, 2025
Version: 1
U955-IMRB, INSERM, Universite Paris-Est Creteil, Ecole Nationale Veterinaire d Alfort, EFS
molecular biology
bioRxiv

CRISPR/Cas13-mediated Dynamin 2 reduction therapy in a canine model of DNM2-related centronuclear myopathy

Carlier, A.Open in Google Scholar•Barthelemy, I.Open in Google Scholar•Blanchard-Gutton, N.Open in Google Scholar•Chateau-Joubert, S.Open in Google Scholar•aurade, F.Open in Google Scholar•Ozturk, T.Open in Google Scholar•Didier, N.Open in Google Scholar•Relaix, F.Open in Google Scholar•Tiret, L.Open in Google Scholar•Blot, S.Open in Google Scholaret al.

We determined the potential of CRISPR/Cas13 technology as a therapeutic approach for centronuclear myopathies (CNMs) by reducing the expression of a single protein, DNM2. CNMs are severe congenital rare muscle disorders that result in muscle hypotrophy and weakness, with no cure. CNMs frequently result from mutations in either BIN1, MTM1, or DNM2 genes, with DNM2 being a key GTPase that plays a pivotal role in muscle membrane interactions with MTM1 and BIN1. Previous studies indicate that reducing DNM2 transcript expression by half could correct CNM phenotypes regardless the genetic forms, paving the way for a broad-spectrum CNM-therapy. We evaluated CRISPR/Cas13X.1-mediated DNM2 transcript knockdown, as a therapeutic application in a unique naturally-occurring canine CNM model harboring the DNM2R465W/+ mutation, the most frequent pathogenic variant in patients. We show that in vivo intramuscular AAV-mediated CRISPR/Cas13X.1 injections, led to a reduction in DNM2 transcript and protein levels at one and two months post-treatment. Our results demonstrate the feasibility of CRISPR/Cas13-based therapy for CNM in a large animal model, paving the way for advancing this approach towards clinical trials.

Similar Papers

bioRxiv
Fri Sep 05 2025
Pivotal role of Disrupted-in-Schizophrenia 1 (DISC1) in cardiac resilience to ischemic stress
Molecular targets that contribute to post-myocardial infarction heart failure remains elusive. Here we studied the global transcriptional landscape of human inducible pluripotent stem cell-derived cardiomyocytes under simulated ischemia at the whole genome level in an unbiased manner. Unexpectedly, we identified Disrupted in Schizophrenia 1 (DISC1), which has been almost exlusively studied in neur...
Gurdeep Marwahra, G.
•
Pinho, M. J.
•
Scrimgeour, N. R.
•
Slagsvold, K. H.
...•
Hoydal, M. A.
bioRxiv
Fri Sep 05 2025
Cross-platform digital PCR evaluation of bovine papilloma virus quantification: introducing PCR-ValiPal for Standardized guided assay validation
Digital Polymerase chain reaction (dPCR) enables precise and absolute quantification of nucleic acids by partitioning samples into thousands of individual PCR micro-reactions. While it minimizes the need for standard curves and enhances reproducibility compared to qPCR, thorough assay validation remains crucial. We introduce PCR-ValiPal, a user-friendly web application that standardizes dPCR assay...
Gleerup, D.
•
Vynck, M.
•
Gysens, L.
•
De Baere, C.
...•
De Spiegelaere, W.
bioRxiv
Fri Sep 05 2025
Genome-wide overexpression screen reveals a novel transcription termination factor in Trypanosoma brucei
Trypanosoma brucei is a protozoan parasite that causes African trypanosomiasis. We performed an overexpression library screen to gain insights into essential cellular processes in T. brucei and identified genes whose overexpression impaired parasite growth. One of the three top-ranking candidates we validated exhibited a notable phenotype. TbFOP, an uncharacterized protein, has an N-terminal argin...
Selvan, N. P.
•
Mukherjee, A.
•
Erben, E.
•
Kim, H.-S.
bioRxiv
Fri Sep 05 2025
N6-Methyladenine DNA modification regulates pathogen virulence in nematodes
The study of the global regulatory mechanisms controlling pathogen virulence gene expression is key to understanding the underlying mechanisms of pathogenicity. 6mA plays a critical role in regulating gene expression in response to various environmental stresses, but its biological functions related to pathogen virulence remain largely unexplored. We report the widespread presence of 6mA across 17...
Dai, D.
•
Zhang, S.
•
Hu, B.
•
Zhou, Y.
...•
Sun, M.
bioRxiv
Fri Sep 05 2025
Deep-mutational scanning libraries using tiled-region exchange mutagenesis
The analysis of gene function frequently requires the generation of mutants. Deep-mutational scanning (DMS) has emerged as a powerful tool to decipher important functional residues within genes and proteins. However, methods for performing DMS tend to be complex or laborious. Here, we introduce Tiled-Region Exchange (T-REx) Mutagenesis, which is a multiplexed modification of the EMPIRIC mutagenesi...
Kindree, K.
•
Chochinov, C. A.
•
Bhachu, K.
•
Cheng, Y.
...•
Nguyen Ba, A. N.
bioRxiv
Fri Sep 05 2025
TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and -independent mitophagy
Activation of innate immune signaling occurs during the progression of immunometabolic diseases, including type 2 diabetes (T2D), yet the impact of innate immune signaling on glucose homeostasis is controversial. Here, we report that the E3 ubiquitin ligase TRAF6 integrates innate immune signals following diet-induced obesity to promote glucose homeostasis through the induction of mitophagy. Where...
Levi-DAncona, E.
•
Walker, E. M.
•
Zhu, J.
•
Deng, Y.
...•
Soleimanpour, S. A.
bioRxiv
Fri Sep 05 2025
Hydra domain drives SNF2L multimerization and marks ISWI diversification in parasites
ISWI chromatin remodelers are conserved regulators of nucleosome positioning and chromatin accessibility across eukaryotes, yet their evolutionary diversification is poorly understood. In the apicomplexan parasite Toxoplasma gondii, we identify Hydra, a previously unrecognized globular domain embedded within TgSNF2L, one of two ISWI paralogues. Hydra is structurally unique, lacking homology to any...
Pachano, B.
•
von Velsen, J.
•
Corrao, C.
•
Mas, C.
...•
Swale, C.
bioRxiv
Fri Sep 05 2025
Enhancers mediate euchromatin hopping at chromatin contact points
Enhancer-mediated gene activation involves the recruitment of chromatin modifiers and RNA polymerase to target promoters, but it is unknown if enhancers influence chromatin beyond their target genes. Euchromatin and heterochromatin associated histone modifications separate the genome into opposing nuclear compartments. Whereas heterochromatin marks are known to spread from one modified nucleosome ...
Mitchell, J. A.
•
Mullany, S.
•
Taylor, T.
•
Li, H.
...•
Davies, J. O.
bioRxiv
Fri Sep 05 2025
P53 supresses transcription of the p300-E2F1-dependent gene subset by maintaining KDM5B associated with gene promoters
p53 is a transcription activator or repressor that acts mainly by having direct control over the expression of CDK inhibitor - p21 in response to DNA damage. In this study, molecular evidence was provided for the occurrence of p53 at the subset of E2F1-driven promoters and their suppression, despite the co-occurrence of p53 with p300. P53 repressed promoters were characterized by relatively high n...
Gronkowska, K.
•
Kolacz-Milewska, K.
•
Michlewska, S.
•
Robaszkiewicz, A.